Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt

被引:38
作者
Nagy, Mohamed [1 ]
Lynch, Meghan [2 ]
Kamal, Sherif [1 ]
Mohamed, Sarah [1 ]
Hadad, Alaa [1 ]
Abouelnaga, Sherif [1 ]
Aquilante, Christina L. [2 ]
机构
[1] Childrens Canc Hosp Egypt, Cairo 57357, Egypt
[2] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA
关键词
attitude; developing country; knowledge; perception; pharmacogenetics; pharmacogenomics;
D O I
10.2217/pme-2019-0163
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: We evaluated healthcare practitioners' perspectives regarding clinical pharmacogenetics in Cairo, Egypt. Materials & methods: We administered a paper-based survey to pharmacists and physicians practicing at Children's Cancer Hospital Egypt. The survey assessed practitioners' knowledge, attitudes, and perspectives about pharmacogenetic testing. Results: The study included 184 respondents (67.9% pharmacists; 32.1% physicians. Overall, the pharmacogenetic knowledge was low (mean = 41.7%) but attitudes toward pharmacogenetic testing and its potential clinical application were generally positive. Pharmacists responded more favorably than physicians to statements attributing the responsibility of applying pharmacogenetics in the clinical setting to their profession. However, several challenges were identified; the most common being: lack of pharmacogenetic knowledge and skill, lack of pharmacogenetic testing devices, and limited funding. Conclusion: Future efforts to promote pharmacogenetic implementation should focus on foundational education, practical training, and exploration of potential funding sources.
引用
收藏
页码:251 / 260
页数:10
相关论文
共 51 条
[41]   The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later [J].
Relling, Mary V. ;
Klein, Teri E. ;
Gammal, Roseann S. ;
Whirl-Carrillo, Michelle ;
Hoffman, James M. ;
Caudle, Kelly E. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) :171-175
[42]   Pharmacogenomics in the clinic [J].
Relling, Mary V. ;
Evans, William E. .
NATURE, 2015, 526 (7573) :343-350
[43]   Pharmacogenomics competencies in pharmacy practice: A blueprint for change [J].
Roederer, Mary W. ;
Kuo, Grace M. ;
Kisor, David F. ;
Frye, Reginald F. ;
Hoffman, James M. ;
Jenkins, Jean ;
Weitzel, Kristin Wiisanen .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (01) :120-125
[44]  
Roederer MW, 2011, PHARMACOGENOMICS, V12, P897, DOI [10.2217/pgs.11.17, 10.2217/PGS.11.17]
[45]   Economic Evaluation of Pharmacogenomics: A Value-Based Approach to Pragmatic Decision Making in the Face of Complexity [J].
Snyder, Susan R. ;
Mitropoulou, Christina ;
Patrinos, George P. ;
Williams, Marc S. .
PUBLIC HEALTH GENOMICS, 2014, 17 (5-6) :256-264
[46]   Integrating Genomics into Healthcare: A Global Responsibility [J].
Stark, Zornitza ;
Dolman, Lena ;
Manolio, Teri A. ;
Ozenberger, Brad ;
Hill, Sue L. ;
Caulfied, Mark J. ;
Levy, Yves ;
Glazer, David ;
Wilson, Julia ;
Lawler, Mark ;
Boughtwood, Tiffany ;
Braithwaite, Jeffrey ;
Goodhand, Peter ;
Birney, Ewan ;
North, Kathryn N. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2019, 104 (01) :13-20
[47]   Continuous pharmacogenomics and genomic medicine education for healthcare professionals through electronic educational courses [J].
Tsermpini, Evangelia-Eirini ;
Stamopoulou, Theano ;
Kordou, Zoe ;
Barba, Evaggelia ;
Siamoglou, Stavroula ;
Stathoulias, Andreas ;
Patrinos, George P. .
PERSONALIZED MEDICINE, 2019, 16 (03) :189-193
[48]  
van der Wouden CH, 2017, CLIN PHARMACOL THER, V101, P341, DOI [10.1002/cpt.602, 10.1002/cpt.725]
[49]   Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory [J].
Vo, Teresa T. ;
Bell, Gillian C. ;
Obeng, Aniwaa Owusu ;
Hicks, J. Kevin ;
Dunnenberger, Henry M. .
PHARMACOTHERAPY, 2017, 37 (09) :1014-1022
[50]   Educational strategies to enable expansion of pharmacogenomics-based care [J].
Weitzel, Kristin Wiisanen ;
Aquilante, Christina L. ;
Johnson, Samuel ;
Kisor, David F. ;
Empey, Philip E. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (23) :1986-1998